Introduction
Pain, anxiety and delirium are common occurrences in an ICU secondary to existing diseases, surgical procedures, trauma, invasive monitors, endotracheal intubation, and nursing interventions [1] [2] [3] . Inadequately treated pain may lead to increased stress response, with resultant tachycardia, increased oxygen consumption, hypercoagulability, immunosuppression, hypermetabolism, and increased endogenous catecholamine activity [4] [5] [6] [7] . Insufficient pain relief can also contribute to deficient sleep, disorientation, anxiety, and long-term effects such as post-traumatic stress disorder [8] .
Analgesia and sedation are therefore used in the ICU to provide comfort and ensure patient safety, especially in those who are mechanically ventilated. Although analgesia and sometimes sedation is necessary in an ICU, when overused without goals and targets, they predispose patients to untoward complications of increased time on mechanical ventilation, longer times in the ICU, more radiological testing for altered mental status, ICUacquired weakness and greater likelihood of delirium [9, 10] .
This state-of-the-art review will focus on the following: delirium, representing an acute or newly acquired cognitive dysfunction; and ICU-acquired weakness, an ICUassociated physical disability, as two areas for intervention, to improve functional outcomes in our critically ill patients. A detailed description of the epidemiology of delirium in trauma patients with emphasis on its relationship with analgesic and sedative medications will be provided, followed by a brief overview of ICU-acquired weakness. Finally, we will provide an evidence-based approach to assist the readers in incorporating best analgesia, sedation and delirium practices, including early ambulation, to improve outcomes in their critically ill patients.
accompanied by inattention, disorganized thinking, and perceptual disturbances that fluctuate over a short period of time [11] .
Prevalence and outcomes
Delirium is commonly underdiagnosed in the ICU and has a reported prevalence of 20-80%, depending on the severity of illness and the need for mechanical ventilation [12] [13] [14] [15] . Whereas the majority of the studies evaluating delirium have been in medical ICU patients, four recent studies have shown delirium rates to be between 50 and 80% in surgical, trauma ICU and burn ICU patients [16] [17] [18] [19] . Delirium can be categorized into subtypes according to psychomotor behavior manifested by patients. Hypoactive delirium patients are characterized by decreased physical and mental activity (lethargy) and inattention, is frequently overlooked by both physicians and nursing staff and may have higher mortality and morbidity [20, 21] . On the other extreme are hyperactive delirium patients who are agitated and combative. Patients exhibiting both characteristics have mixed delirium. Evaluation of the subtypes of delirium has revealed that hypoactive delirium is often the more prevalent form of delirium in surgical and trauma patients; Pandharipande et al. [22] found that 64% of surgical and 60% of trauma ICU patients had hypoactive delirium. Angles et al. [18] in their smaller study of trauma patients found the incidence of hypoactive delirium to be 46%, hyperactive delirium to be 15%, and mixed at 39%, whereas Agarwal et al. [19] reported rates of 71% hypoactive delirium, 22% mixed delirium, and 6% pure hyperactive delirium in their study looking at burn trauma patients.
Historically, delirium was considered an inconsequential occurrence during critical illness. Unfortunately, recent investigations have shown that delirium is independently associated with worse outcomes as seen with other organ dysfunctions. The presence of delirium is a strong predictor of longer hospital stay, greater times on mechanical ventilation, higher costs and more alarmingly, increased risk of death [17,23,24,25 ,26 ] . Additionally, each additional day with delirium increases the risk of dying by 10% [12, 27 ]. Longer periods of delirium are also associated with greater degrees of cognitive decline, when patients are evaluated after 1 year [25 ] .
Diagnosis of delirium
Numerous national and international surveys have highlighted the importance of recognizing delirium in the ICU [28] [29] [30] [31] [32] [33] [34] [35] . Most of these surveys show a disconnect between the perceived importance of delirium and the accuracy of diagnosis, and implementation of management and treatment techniques. Therefore, ICU providers must move beyond just knowledge and awareness about delirium, towards implementation of validated screening tools to diagnose delirium. It is especially important to develop instruments that can be used readily by nurses at the bedside who may not have experience or skill in psychiatric assessment.
Delirium assessment instruments
Devlin et al. [36, 37] have shown that using validated assessment tools can improve the ability of both physicians [36] as well as nurses [37] to detect delirium at the bedside. We will discuss two instruments that have been extensively studied and implemented in ICUs for use in nonverbal patients.
The Confusion Assessment Method for ICU (CAM-ICU) [38] : The Confusion Assessment Method for ICU (CAM-ICU) (Fig. 1) is a reliable and validated [38] [39] [40] instrument for diagnosing delirium. It has a high specificity and sensitivity, is easy to use, and takes approximately 60-90 s to administer. Patients are first evaluated for a level of consciousness and if they respond to verbal commands (e.g. a Richmond Agitation-Sedation score of À3 or higher) [41] then they are assessed for delirium. Largescale implementation studies [42, 43] have been performed, including in trauma patients, showing good reliability and compliance of delirium monitoring by bedside nurses.
Intensive care delirium screening checklist [44] : This is a validated [44, 45] , eight-item based screening checklist for delirium (Table 1 ). The patient is evaluated for inattention, disorientation, hallucination, delusion or psychosis, psychomotor agitation or retardation, inappropriate speech or mood, sleep-wake cycle disturbance, and fluctuation of the above symptoms. Each item is scored as absent or present (0 or 1) and summed. A score of at least 4 indicates delirium, whereas 0 indicates no delirium.
Patients with scores between 1 and 3 are considered to have subsyndromal delirium [46] . Patients with subsyndromal delirium have some but not all features of delirium and have outcomes that are in-between those of patients with no delirium and those with delirium [46] .
Pathophysiology of delirium
The pathogenesis of delirium is poorly understood. Numerous hypotheses exist which include neurotransmitter imbalance [e.g. dopamine, g-aminobutyric acid (GABA), and acetylcholine]; inflammatory perturbations [e.g. tumor necrosis factor (TNF)-a, interleukin (IL)-1, and other cytokines/chemokines]; impaired oxidative metabolism; cholinergic deficiency and changes in various amino acid precursors [47, 48] .
Risk factors for delirium
Risk factors for the development of delirium are multifactorial and can be divided into host factors (age, baseline comorbidities, baseline cognitive impairment and genetic predisposition), factors of acute illness (sepsis, hypoxemia and metabolic disturbances) and iatrogenic and environmental factors (metabolic disturbances, anticholinergic medications, sedatives and analgesic medications and sleep disturbances) [49] [50] [51] [52] . Primary central nervous system disease, shock, liver disease, acute respiratory distress syndrome, postoperative status, kidney disease, heart failure, and anemia have also been associated with delirium [15] .
Sedative and analgesics as risk factors for delirium
In studies specific to the trauma ICU, sedatives and analgesics were found to be risk factors for development of delirium by both Pandharipande et al. [16] and Lat et al. [17] . Specifically, Pandharipande et al. [16] reported that exposure to midazolam was an independent risk factor for the development of delirium in both surgical and trauma patients; the association between opioid medications and delirium was inconsistent with fentanyl being a risk factor
Epidemiology of delirium and ICU-acquired weakness Banerjee et al. 197 for delirium in surgical ICU patients but not in trauma patients and morphine being associated with a lower risk of delirium in the trauma ICU patients. This difference can be explained by the fact that fentanyl as an infusion may be used additionally as a sedative rather than just an analgesic, leading to higher incidences of delirium. Morphine, on the contrary, was used in bolus doses for analgesia, and thus protective. Similar results were seen in a study performed in the burn trauma patients [19] , in which exposure to benzodiazepines was an independent risk factor for the development of delirium {odds ratio [OR] 6.8 [confidence interval (CI) 3.1-15], P < 0.001}. Similar to the trauma patients, exposure to both intravenous opiates [0.5 (0.4-0.6), P < 0.001] and methadone [0.7 (0.5-0.9), P ¼ 0.2] were associated with lower odds of developing delirium, leading us to believe that appropriate pain control in populations at risk for severe pain (trauma, burn, etc.) reduces delirium risk. In contrast, in the study by Lat et al. [17] the patients who developed delirium were exposed to higher cumulative doses of both lorazepam and fentanyl; however, this study did not assess the temporal relationship of drug administration and delirium as done in the Pandharipande et al. study. Angles et al. [18] showed that lower Glasgow coma score at admission, increased blood transfusion and higher multiorgan failure scores (thus many markers of severity of illness) were associated with increased delirium. Their study could not assess whether sedatives and analgesics were associated with higher delirium rates.
ICU-acquired weakness
ICU-acquired weakness has been known to occur in 25-60% of patients who regain normal consciousness after an ICU stay [10] . It is an acute-onset neuromuscular functional impairment in critically ill patients, who have no prior history of neuromuscular disorders. Immobility and bed rest play an important role in the development of muscular weakness [53] . In 2003 Herridge et al. [54] studied 109 survivors of acute respiratory distress syndrome (ARDS) and followed them at 3, 6 and 12 months after discharge from the ICU. They found that most patients at 1 year have functional disability with muscle weakness and wasting being the most prominent feature. These findings have led to studies looking at the feasibility of starting physical therapy and mobility exercises on patients while on mechanical ventilation [55] . Apart from immobility, other risk factors of ICU-acquired weakness include multiple organ failure, prolonged sedation with muscle inactivity, hyperglycemia, and the use of certain drugs like corticosteroids and neuromuscular blockers. Mechanical ventilation for greater than 1 week has been shown to be an independent risk factor for the disorder. Patients with ICU-acquired weakness have longer ICU and hospital stays, higher mortality and survivors experience disability for weeks to months [10] .
Management
Over the past decade we have improved and mastered many life-saving maneuvers in our ICUs -aggressive resuscitation, source control of infection, antibiotics, and so on. Now it is important that we focus on improving patient outcome and recovery. To do this we need to focus on strategies to 'liberate' our patients from mechanical ventilation then 'animate' them by getting them out of bed early.
The ABCDE bundle for optimal management of analgesia, sedation and delirium
To improve patient outcome and recovery we present an evidence-based organizational approach referred to as the ABCDE bundle (Awakening and Breathing Trials, Choice of appropriate sedation, Delirium monitoring and Early mobility and Exercise).
Awaken the patient daily
Benzodiazepines are known to increase the risk of delirium in a dose-dependent manner [16, 52] . Multiple studies have shown that protocolized target-based sedation and daily spontaneous awakening trials reduce the number of days on mechanical ventilation. This strategy also exposes the patient to smaller cumulative doses of sedatives [9, 56] .
Spontaneous breathing trials
This involves daily interruption of mechanical ventilation. Spontaneous breathing trials were shown to be superior to other varied approaches to ventilator weaning [57] . Thus incorporation of spontaneous breathing trials into practice reduced the total time on mechanical ventilation.
Coordination of daily awakening and daily breathing
The awakening and breathing controlled trial [58] combined the spontaneous awakening trial with the spontaneous breathing trial. This combination showed shorter duration of mechanical ventilation, a 4-day reduction in hospital length of stay, a remarkable 15% decrease in 1-year mortality and no long-term neuropsychological consequences of waking patients during critical illness [59] .
Choosing the right sedative regimen in critically ill patients Numerous studies have identified that benzodiazepines are associated with a worse clinical outcome [50, 52, 60] , necessitating attention to the choice of sedation one decides to utilize for one's patients. In a study comparing propofol to intermittent lorazepam, Carson et al. [61] found that in patients requiring more than 48 h of mechanical ventilation, sedation with propofol resulted in shorter ventilator times than lorazepam, even when sedatives were interrupted daily. Breen et al. [62] compared a sedation regimen using remifentanil to midazolam and found that the remifentanil-based sedation regimen decreased duration of mechanical ventilation and the time from the start of weaning to extubation. Two studies comparing sedation protocols using dexmedetomidine (a 2 agonist) to benzodiazepine infusions showed similar results. The MENDS [63] showed more days alive without delirium or coma (7.0 vs. 3.0; P ¼ 0.01), with a lower risk of developing delirium on subsequent days if on dexmedetomidine compared to lorazepam [64] . The SEDCOM [65] study also showed a decrease in delirium prevalence in the dexmedetomidine group [54 vs. 76 .6% (95% CI 14-33%), P < 0.001], with shorter times on mechanical ventilation.
Delirium management
The Society of Critical Care Medicine (SCCM) has published guidelines recommending routine monitoring for delirium in all ICU patients [4] . Pharmacologic therapy for delirium should only be attempted after correcting any contributing factors or underlying physiologic abnormalities. Patients, who manifest delirium, should be treated with a traditional antipsychotic medication (haloperidol), as per the SCCM guidelines [66] . A recommended starting dose is 2-5 mg every 6-12 h (i.v. or p.o.); the maximal effective doses are usually around 20 mg/day. Newer 'atypical' antipsychotic agents (e.g. risperidone, ziprasidone, quetiapine, or olanzapine) also may prove helpful for the treatment of delirium [67] . Whereas the MIND study [68] showed no difference in the duration of delirium between haloperidol, ziprasidone or placebo, when used for prophylaxis and treatment, a smaller study done by Devlin et al. [69] showed that quetiapine was more effective than placebo in resolution of delirium when supplementing ongoing haloperidol therapy. Data from the MENDS [63, 64] study and the SEDCOM trial [65] support the view that dexmedetomidine can decrease the duration and prevalence of delirium when compared to lorazepam or midazolam. Benzodiazepines remain the drug of choice for the treatment of delirium tremens (and other withdrawal syndromes) and seizures.
Exercise and early mobility
Morris et al. [70] showed that initiating physical therapy early during the patients ICU stay was associated with decreased length of stay both in an ICU as well as in the hospital. In this prospective cohort study the investigators assessed the effect of introducing a mobility protocol in the ICU. They found that patients in the study group patients received at least one more physical therapy session than the control group (80 vs. 47%; P < 0.001), were out of bed earlier (5 vs. 11 days; P < 0.001), had therapy initiated more frequently (91 vs. 13%; P < 0.001), with no differences in the complication rates. Schweickert et al. [71 ] looked at the efficacy of combining daily interruption of sedation with physical and occupational therapy to see if it had an impact on the development of ICU-acquired weakness and delirium in mechanically ventilated patients. They found that patients who underwent early mobilization had a significant improvement in functional status at hospital discharge. These patients also had a significant decrease in the duration of delirium (50%) in the ICU as well as during the hospital stay. At 28 days patients also had more ventilator-free days (23.5 
Conclusion
ICU delirium and ICU-acquired weakness are associated with higher costs, hospital length of stay and worse outcomes. These devastating complications of critical illness may be preventable or their duration and course mitigated via close attention to practices in the ICU. We propose implementation of a bundle of processesawakening and breathing coordination, choice of appropriate sedative, delirium monitoring, and exercise/early mobility -or the ABCDE bundle, to improve functional and cognitive abilities of survivors of critical illness.
